You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 6, Issue 2

February 2013 - 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Review
  • Open Access
35 Citations
11,000 Views
18 Pages

cGMP-Dependent Protein Kinase Inhibitors in Health and Disease

  • Stefanie Wolfertstetter,
  • Johannes P. Huettner and
  • Jens Schlossmann

7 February 2013

cGMP-dependent protein kinases (PKG) exhibit diverse physiological functions in the mammalian system e.g., in vascular and gastrointestinal smooth muscles, in platelets, in kidney, in bone growth, nociception and in the central nervous system. Furthe...

  • Article
  • Open Access
37 Citations
9,279 Views
20 Pages

Relationships between Cargo, Cell Penetrating Peptides and Cell Type for Uptake of Non-Covalent Complexes into Live Cells

  • Andrea-Anneliese Keller,
  • Franziska Mussbach,
  • Reinhard Breitling,
  • Peter Hemmerich,
  • Buerk Schaefer,
  • Stefan Lorkowski and
  • Siegmund Reissmann

6 February 2013

Modulating signaling pathways for research and therapy requires either suppression or expression of selected genes or internalization of proteins such as enzymes, antibodies, nucleotide binding proteins or substrates including nucleoside phosphates a...

  • Article
  • Open Access
15 Citations
8,704 Views
19 Pages

Elucidating the Function of Penetratin and a Static Magnetic Field in Cellular Uptake of Magnetic Nanoparticles

  • Suman Chaudhary,
  • Carol Anne Smith,
  • Pablo Del Pino,
  • Jesus M. De la Fuente,
  • Margaret Mullin,
  • Andrew Hursthouse,
  • David Stirling and
  • Catherine C. Berry

6 February 2013

Nanotechnology plays an increasingly important role in the biomedical arena. In particular, magnetic nanoparticles (mNPs) have become important tools in molecular diagnostics, in vivo imaging and improved treatment of disease, with the ultimate aim o...

  • Review
  • Open Access
81 Citations
14,376 Views
28 Pages

RNAi Therapeutic Platforms for Lung Diseases

  • Yu Fujita,
  • Fumitaka Takeshita,
  • Kazuyoshi Kuwano and
  • Takahiro Ochiya

6 February 2013

RNA interference (RNAi) is rapidly becoming an important method for analyzing gene functions in many eukaryotes and holds promise for the development of therapeutic gene silencing. The induction of RNAi relies on small silencing RNAs, which affect sp...

  • Review
  • Open Access
53 Citations
22,288 Views
18 Pages

NMDA Receptor Modulators in the Treatment of Drug Addiction

  • Seven E. Tomek,
  • Amber L. Lacrosse,
  • Natali E. Nemirovsky and
  • M. Foster Olive

6 February 2013

Glutamate plays a pivotal role in drug addiction, and the N-methyl-D-aspartate (NMDA) glutamate receptor subtype serves as a molecular target for several drugs of abuse. In this review, we will provide an overview of NMDA receptor structure and funct...

  • Review
  • Open Access
155 Citations
12,530 Views
23 Pages

Dendrimers for siRNA Delivery

  • Swati Biswas and
  • Vladimir P. Torchilin

4 February 2013

Since the discovery of the “starburst polymer”, later renamed as dendrimer, this class of polymers has gained considerable attention for numerous biomedical applications, due mainly to the unique characteristics of this macromolecule, including its m...

  • Review
  • Open Access
28 Citations
16,164 Views
37 Pages

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning

  • Olivia Perwitasari,
  • Abhijeet Bakre,
  • S. Mark Tompkins and
  • Ralph A. Tripp

28 January 2013

Bridging high-throughput screening (HTS) with RNA interference (RNAi) has allowed for rapid discovery of the molecular basis of many diseases, and identification of potential pathways for developing safe and effective treatments. These features have...